EFS Investment & Incubation Business
We are committed to being a collaborative platform for Innovative Biotech companies from around the world.

Viva Biotech combines conventional cash for service (CFS) and unique equity for service (EFS) business models, maintaining steady cash in flow from short-term drug discovery services while realizing massive revenue from long-term investments in drugs incubation. As the investment division of Viva Biotech Holdings (1873.HK), we are committed to being a collaborative platform for Innovative Biotech companies from around the world.

  • 90Portfolio Companies
  • 199Pipelines in Total
Our Investment Strategy
Areas of Exploration On Promising Biotech StartUps
Indications
Mechanism
Locations
Our Advantages — Optimized Incubation Platform

Viva BioInnovator works with some of the world’s brightest minds to help discover novel and life-changing therapeutics. We can assist our portfolio companies through several avenues, including CRO services, financial support, access to experts, industry networks, back-office operations, and more.

We continuously seek innovative ideas and set no restrictions on the indication, drug type, or company location. All companies we invest in have access to capital and expert guidance. However, for a select few companies, Viva BioInnovator can act as a hands-on incubator to assist in company creation and development. Selected portfolio companies can choose what support they want from the investment and incubation tracks.

CRO Service

· Our leading CRO platform is productive and efficient.

· Enables both quick and quality drug candidate discovery.

Experts

· Business Partners (experts in business operation and compliance)

· Venture Advisors (experts in science and drug development)

Capital

· Average time to invest: 2 months

· Introductions for later-stage funding and financial advice

Industry Network

· Assistance in procuring internal or external resources (MNC R&D, B&D)

· Will alert founders to changes in market dynamics

Operation

· Lab and office locations in Shanghai, Jiaxing, Chengdu, Hangzhou, Boston, San Diego, etc.

· "Back-office" support (HR, Accounting, Procurement, BD, Financing, etc.)

  • CRO Service

    · Our leading CRO platform is productive and efficient.

    · Enables both quick and quality drug candidate discovery.

  • Experts

    · Business Partners (experts in business operation and compliance)

    · Venture Advisors (experts in science and drug development)

  • Capital

    · Average time to invest: 2 months

    · Introductions for later-stage funding and financial advice

  • Industry Network

    · Assistance in procuring internal or external resources (MNC R&D, B&D)

    · Will alert founders to changes in market dynamics

  • Operation

    · Lab and office locations in Shanghai, Jiaxing, Chengdu, Hangzhou, Boston, San Diego, etc.

    · "Back-office" support (HR, Accounting, Procurement, BD, Financing, etc.)

Our Team

Viva BioInnovator has a professional, progressive, and practical investment team. The team members have a rich experience in entrepreneurship, management, operation, R&D, and investment in the medical industry. Additionally, an expert team of more than 30 world-class scientists and entrepreneurs from home and abroad will be involved in the project, working closely during the due diligence process, and providing advice on entrepreneurship, management, and scientific development for incubators.

Our Ecosystem

We continue building and optimizing the biomedical ecosystem while enhancing open cooperation platforms. We believe in a win-win partnership for our clients on the path to global innovation and development. Viva Biotech launched activities like the Annual Partnership Summit and Demo Day to encourage an open, creative atmosphere for Viva incubators. We constantly strive to promote and participate in pharmaceutical innovation and hope to create a positive impact through cooperation and achieve notable results for all parties.

To get more information about EFS BusinessPlease visit Viva BioInnovator website

×